Cardiogenic Shock, High Risk PCI
Conditions
Brief summary
The population enrolled in this study are all subjects who received an Impella in which a bicarbonate-based purge solution was used.
Interventions
DEVICEImpella CP, 2.5, 5.0 and 5.5 with Sodium Bicarbonate used as purge solution
US commercially approved Abiomed left sided hemodynamic support devices (Impella) will be included.
DEVICEImpella RP with Sodium Bicarbonate used as purge solution
US commercially approved Abiomed right sided hemodynamic support devices (Impella) will be included.
Sponsors
Abiomed Inc.
Study design
Observational model
OTHER
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
Left Sided Impella Inclusion Criteria: * Left-sided Impella with bicarbonate in the purge
Exclusion criteria
* Known LV thrombus Right Sided Impella Inclusion Criteria: * Right-sided Impella with bicarbonate in the purge
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Primary Endpoint Left Sided Impella | From hospital admission until hospital discharge, average 5 days | Rate of heiarchical composite of stroke, transient ischemic attack (TIA), left ventricular (LV) thrombus |
| Primary Endpoint Right Sided Impella | From hospital admission until hospital discharge, average 5 days | Rate of heiarchical composite of pulmonary thromboemboli and deep vein thrombosis (DVT) |
Countries
United States
Outcome results
None listed